Literature DB >> 7579071

Megalin (gp330) possesses an antigenic epitope capable of inducing passive Heymann nephritis independent of the nephritogenic epitope in receptor-associated protein.

R A Orlando1, D Kerjaschki, M G Farquhar.   

Abstract

The Heymann nephritis antigenic complex (HNAC) consists of two glycoproteins, megalin (gp330), and the receptor-associated protein (RAP). HNAC is expressed on the surface of the glomerular epithelium where it plays a primary role in the pathogenesis of Heymann nephritis (HN). Several models were previously proposed describing how antibody binding epitopes in HNAC may contribute to the initiation and progression of HN. Although these models suggest that nephritogenic epitopes capable of initiating HN are present in both megalin and RAP, the structural relationship between these epitopes has not been established. Previously a nephritogenic epitope was identified and characterized in RAP that initiates immune complex formation in HN. In this report, the immunologic relationship between nephritogenic epitopes in megalin and RAP were examined to determine whether these epitopes are immunologically distinct or antigenically related. To this end, a polyclonal antibody to megalin was generated that does not recognize RAP by immunoblotting or immunoprecipitation and whether this antibody is capable of inducing passive HN was determined. It was found that antimegalin antibodies devoid of RAP cross-reactivity induced the formation of subepithelial immune deposits (passive HN) when injected into rats. Antibodies eluted from glomeruli of the injected rats recognized only megalin by immunoblotting a cortical extract and did not recognize a RAP fusion protein or any other renal protein. In addition, the eluted antibodies immunoprecipitated two proteolytic fragments of megalin (140 and 75 kd) identifying a pathogenic epitope within a smaller fragment of megalin.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7579071     DOI: 10.1681/ASN.V6161

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  7 in total

1.  Gene expression and immunohistochemical localization of megalin in the anterior pituitary gland of helmeted guinea fowl (Numida meleagris).

Authors:  Claudius Luziga; Masaru Usui; Horii Yoichiro; Rudovick Kazwala; Yoshimi Yamamoto; Koichi Mamba
Journal:  J Mol Histol       Date:  2007-02-09       Impact factor: 2.611

Review 2.  Molecular analysis of the pathological autoimmune antigens of Heymann nephritis.

Authors:  M G Farquhar
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

3.  Mapping rat megalin: the second cluster of ligand binding repeats contains a 46-amino acid pathogenic epitope involved in the formation of immune deposits in Heymann nephritis.

Authors:  A Saito; H Yamazaki; K Rader; A Nakatani; R Ullrich; D Kerjaschki; R A Orlando; M G Farquhar
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

4.  Pathogenic antibodies inhibit the binding of apolipoproteins to megalin/gp330 in passive Heymann nephritis.

Authors:  D Kerjaschki; M Exner; R Ullrich; M Susani; L K Curtiss; J L Witztum; M G Farquhar; R A Orlando
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

5.  Induction of Heymann nephritis with a gp330/megalin fusion protein.

Authors:  R Raychowdhury; G Zheng; D Brown; R T McCluskey
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

Review 6.  The unfolding story of megalin (gp330): now recognized as a drug receptor.

Authors:  M G Farquhar
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

7.  Induction of passive Heymann nephritis with antibodies specific for a synthetic peptide derived from the receptor-associated protein.

Authors:  D Kerjaschki; R Ullrich; M Exner; R A Orlando; M G Farquhar
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.